{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:17Z","timestamp":1792773377871,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"abstract":"<jats:p>\n                    Atrial fibrillation (AF) is a very common type of cardiac arrhythmia. Use of an anticoagulant is highly recommended. We aimed to identify the pattern of prescribing of an oral anticoagulant (OA) in patients with AF and severe dementia or patients with AF aged\u2005&gt;\u200580 years. A retrospective review of medical charts was conducted in 2 tertiary care centers in Riyadh, Saudi Arabia: King Saud University Medical City and King Abdulaziz Medical City. Data for people with AF retrieved between January 2016 and December 2020 from hospital information systems. Collected data included demographics, medical history, medication history (including use of an OA or antiplatelet agent), stroke and major bleeding history. Adjusted binary logistic regression was used to predict the odds ratio (OR) of the primary outcome and secondary outcomes. The data of 620 patients were assessed. Most (60%) were women. The average age of study cohort was 79\u2005\u00b1\u20056.1 years. Most patients (88.2%) were prescribed an OA. The most commonly prescribed OA was a direct inhibitor of factor Xa (DIFXa; 48%), followed by a coumarin derivative (36%), and direct inhibitor of thrombin (16%). Patients using a coumarin derivative carried higher OR of developing severe dementia (adjusted OR\u2005=\u20052.687, 95%CI\u2005=\u20051.795\u20134.021,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    -value\u2005&lt;\u2005.001). Most patients suffering from AF were prescribed an OA. A DIFXa inhibitor was the most prescribed OA. Use of a coumarin derivative carried a high prevalence of dementia among our study cohort.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042343","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T21:01:29Z","timestamp":1747083689000},"page":"e42343","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pattern of anticoagulation prescription for elderly atrial fibrillation patients with or without severe dementia: A retrospective analysis of patient data"],"prefix":"10.1097","volume":"104","author":[{"given":"Abdulrahman M.","family":"AlTuraiki","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Care, Ministry of the National Guard \u2013 Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya M.","family":"AlMalag","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad M.","family":"AlShehri","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumanah M.","family":"AlKendi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanoud M.","family":"AlAnazi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Ministry of the National Guard \u2013 Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal A.","family":"AlAbdulkarim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Ministry of the National Guard \u2013 Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-6870","authenticated-orcid":false,"given":"Shiekha S.","family":"AlAujan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.121.023098","article-title":"Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population-based cohort study.","volume":"11","author":"Bezabhe","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R2-20261023","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2230-8229.83374","article-title":"Clinical characteristics of patients with atrial fibrillation at a tertiary care hospital in the central region of Saudi Arabia.","volume":"18","author":"Bin Salih","year":"2011","journal-title":"J Family Community Med"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"e003932","DOI":"10.1161\/JAHA.116.003932","article-title":"Atrial fibrillation patients treated with long-term warfarin anticoagulation have higher rates of all dementia types compared with patients receiving long\u2010term warfarin for other indications.","volume":"5","author":"Bunch","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R4-20261023","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation.","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"R5-20261023","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1007378","article-title":"Newly identified events in the RE-LY trial.","volume":"363","author":"Connolly","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-20261023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.wnl.0000310773.65918.cd","article-title":"Prevalence of dementia after age 90.","volume":"71","author":"Corrada","year":"2008","journal-title":"Neurology"},{"key":"R7-20261023","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/WNL.0000000000000145","article-title":"Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation.","volume":"82","author":"Culebras","year":"2014","journal-title":"Neurology"},{"key":"R8-20261023","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation.","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"R9-20261023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1532-5415.1996.tb00908.x","article-title":"Cognitive impairment and risk of stroke in the older population.","volume":"44","author":"Verruca","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"R10-20261023","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation.","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"R11-20261023","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R13-20261023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2016.04.039","article-title":"Long-term population-based cerebral ischemic event and cognitive outcomes of direct oral anticoagulants compared with warfarin among long-term anticoagulated patients for atrial fibrillation.","volume":"118","author":"Jacobs","year":"2016","journal-title":"Am J Cardiol"},{"key":"R14-20261023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15420\/AER.2015.04.02.100","article-title":"Anticoagulation in atrial fibrillation \u2013 current concepts.","volume":"04","author":"Katritsis","year":"2015","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"R15-20261023","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2396987319841187","article-title":"Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline.","volume":"4","author":"Klijn","year":"2019","journal-title":"Eur Stroke J"},{"key":"R16-20261023","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"R17-20261023","first-page":"242","article-title":"Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: a multicenter registry.","volume":"16","author":"Krittayaphong","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"R18-20261023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/FJC.0000000000000925","article-title":"Association of risk of dementia with direct oral anticoagulants versus warfarin use in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.","volume":"77","author":"Lee","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"R19-20261023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ahj.2018.03.003","article-title":"Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.","volume":"200","author":"Lubitz","year":"2018","journal-title":"Am Heart J"},{"key":"R20-20261023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mayocp.2017.09.021","article-title":"Efficacy of warfarin anticoagulation and incident dementia in a community-based cohort of atrial fibrillation.","volume":"93","author":"Madhavan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"R21-20261023","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"R22-20261023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"R23-20261023","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1532-5415.1999.tb03839.x","article-title":"Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.","volume":"47","author":"Moroney","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"R25-20261023","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R26-20261023","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis.","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R27-20261023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0256-4947.81536","article-title":"Atrial fibrillation in Saudi patients.","volume":"31","author":"Qanash","year":"2011","journal-title":"Ann Saudi Med"},{"key":"R28-20261023","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia.","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"R29-20261023","first-page":"360","article-title":"Patterns of atrial fibrillation at a regional hospital in Saudi Arabia.","volume":"8","author":"Shatoor","year":"1998","journal-title":"Ethn Dis"},{"key":"R30-20261023","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archneur.56.5.587","article-title":"Aging and the occurrence of dementia.","volume":"56","author":"von Strauss","year":"1999","journal-title":"Arch Neurol"},{"key":"R31-20261023","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:00:56Z","timestamp":1792767656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042343","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}